- Home
- LGL vs HOOK Comparison
LGL vs HOOK Comparison
Compare LGL & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGL
- HOOK
- Stock Information
- Founded
- LGL 1917
- HOOK 2011
- Country
- LGL United States
- HOOK United States
- Employees
- LGL N/A
- HOOK N/A
- Industry
- LGL Industrial Machinery/Components
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- LGL Technology
- HOOK Health Care
- Exchange
- LGL Nasdaq
- HOOK Nasdaq
- Market Cap
- LGL 32.4M
- HOOK 36.9M
- IPO Year
- LGL N/A
- HOOK 2019
- Fundamental
- Price
- LGL $6.12
- HOOK $3.59
- Analyst Decision
- LGL
- HOOK Strong Buy
- Analyst Count
- LGL 0
- HOOK 4
- Target Price
- LGL N/A
- HOOK $39.25
- AVG Volume (30 Days)
- LGL 4.9K
- HOOK 45.7K
- Earning Date
- LGL 11-19-2024
- HOOK 11-22-2024
- Dividend Yield
- LGL N/A
- HOOK N/A
- EPS Growth
- LGL N/A
- HOOK N/A
- EPS
- LGL 0.07
- HOOK N/A
- Revenue
- LGL $3,929,000.00
- HOOK $52,163,000.00
- Revenue This Year
- LGL N/A
- HOOK $155.36
- Revenue Next Year
- LGL N/A
- HOOK N/A
- P/E Ratio
- LGL $78.69
- HOOK N/A
- Revenue Growth
- LGL 599.11
- HOOK 227.80
- 52 Week Low
- LGL $4.42
- HOOK $3.42
- 52 Week High
- LGL $6.76
- HOOK $11.30
- Technical
- Relative Strength Index (RSI)
- LGL 54.82
- HOOK 36.70
- Support Level
- LGL $5.85
- HOOK $3.58
- Resistance Level
- LGL $6.21
- HOOK $4.03
- Average True Range (ATR)
- LGL 0.24
- HOOK 0.23
- MACD
- LGL 0.01
- HOOK 0.01
- Stochastic Oscillator
- LGL 72.92
- HOOK 13.22
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.